New-Born Screening Equipment Market – Growth & Forecast 2022-2032

New-Born Screening Equipment Market Overview

Global new-born screening equipment sales were valued at around USD 485 Million at the end of 2021. The market is projected to register a 7.8% CAGR and top a valuation of USD 1100 Milllion by 2032.

Rapid technological advancement, rise in demand for new-born diagnosis and growing need for infant s safety are expected to uplift the new-born screening equipment market growth.

Neonatal screening, often known as new-born screening, is a process to identify certain developmental, harmful, genetic, or metabolic problems that, if left untreated, may cause mental retardation or even death.

New-born screening is a public health initiative carried out by a number of hospitals where new-borns are checked and found with rare but critical medical disorders such as hormonal, genetic or metabolic conditions that may impede their development. In certain circumstances, the symptoms or signs are absent but the disorder can still be recognized with the help of screening. New-born screening is crucial since it can identify numerous diseases or birth defects that can be treated effectively and save a new-born's life.

Attributes	Details
New-Born Screening Equipment Market Value in 2021	USD 485 Million
New-Born Screening Equipment Market Value in 2032	USD 1100 Million
New-Born Screening Equipment Market CAGR (2022 to 2032)	7.8%

What are the Major Drivers Boosting the Demand for New-Born Screening Equipment Market?

The market for new-born screening equipment is fuelled by the prevalence of neonatal diseases has increased, leading to a dramatic increase in mortality rates. Furthermore, securing funding from government sectors for new-born screening, improving new-born screening programs, and advancements in technologies in new-born screening are all contributing factors to the market's expansion.

Additionally, rising congenital disease incidence in infants is also anticipated to raise demand for new-born screening equipment. Nowadays, the increasing infant population is one of the major drivers to boost the market expansion of new-born screening equipment. Furthermore, the development of oximeters and mass spectrometers with increased performance is anticipated to boost market expansion.

Which Region Shows Strong Growth Potential in the New-Born Screening Equipment Market?

Due to expanding testing requirements throughout all 50 states and the rising prevalence of congenital diseases, North America dominates the market for new-born screening equipment. To increase awareness, state health agencies in the U.S. have published free information and developed websites, which make it easier for parents to deal with congenital diseases. This is the most prominent reason behind the market expansion in this region.

The new-born screening equipment market in Europe is expected to expand at a rapid pace. Advancements in the healthcare industry and the presence of well-established key players boost the market expansion in this region. Due to awareness campaigns, new-born diagnostic procedure quality assurance and rising birth rate, the South and East Asia markets are displaying a lucrative growth opportunity.

Who are the Key Players in the New-Born Screening Equipment Market?

Some of the market players operating in the new-born screening equipment market are Gilent Technologies, Bio-Rad Laboratories, Covidien PLC, GE Life Sciences, Masimo Corporation, Natus Medical Inc., PerkinElmer Inc., Trivitron Healthcare, GE Healthcare, and ZenTech S.A.

Scope of Report

Report Attributes	Details
Growth Rate	CAGR of 7.8% 2022 to 2032
Base Year for Estimation	2021
Historical Data	2012 to 2021
Forecast Period	2022 to 2032
Qualitative Units	Revenue in USD Billion, and CAGR from 2022 to 2032
Report Coverage	Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis
Segment Covered	Product, Test Type, Technology, End User, Region
Region Covered	North America; Latin America; Europe; East Asia; South Asia; Oceania; Middle East & Africa
Key Countries Profiled	USA, Canada, Brazil, Mexico, Germany, UK, France, Spain, Italy, China, Japan, South Korea, Malaysia, Singapore, Australia, New Zealand, GCC, South Africa, Israel
Key Players	Gilent Technologies; Bio-Rad Laboratories; Covidien PLC; GE Life Sciences; Masimo Corporation; Natus Medical Inc.; PerkinElmer Inc.; Trivitron Healthcare; GE Healthcare; ZenTech S.A
Customization	Available Upon Request

Table of Content

• 1. Executive Summary
• 2. Industry Introduction, including Taxonomy and Market Definition
• 3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments
• 4. Global Market Demand Analysis and Forecast, including Historical Analysis and Future Projections
• 5. Pricing Analysis
• 6. Global Market Analysis and Forecast
  • 6.1. Product
  • 6.2. Test Type
  • 6.3. Technology
  • 6.4. End User
• 7. Global Market Analysis and Forecast, By Product
  • 7.1. Hearing Screening Devices
  • 7.2. Pulse Oximetry
  • 7.3. Mass Spectrometer
  • 7.4. Assay Kits
• 8. Global Market Analysis and Forecast, By Test Type
  • 8.1. Dry Blood Spot Tests
  • 8.2. Hearing Screening Tests
  • 8.3. Critical Congenital Heart Disease (CCHD) Screening Tests
• 9. Global Market Analysis and Forecast, By Technology
  • 9.1. Immunoassays & Enzymatic Screening Tests
  • 9.2. Hearing Screening Technologies
  • 9.3. Molecular Assays
  • 9.4. Pulse Oximetry
  • 9.5. Tandem Mass Spectrometry
  • 9.6. Other
• 10. Global Market Analysis and Forecast, By End User
  • 10.1. Clinical Laboratories
  • 10.2. Hospitals
  • 10.3. Diagnostic Centers
  • 10.4. Others
• 11. Global Market Analysis and Forecast, By Region
  • 11.1. North America
  • 11.2. Latin America
  • 11.3. Europe
  • 11.4. East Asia
  • 11.5. South Asia
  • 11.6. Oceania
  • 11.7. Middle East and Africa (MEA)
• 12. North America Sales Analysis and Forecast, by Key Segments and Countries
• 13. Latin America Sales Analysis and Forecast, by Key Segments and Countries
• 14. Europe Sales Analysis and Forecast, by Key Segments and Countries
• 15. East Asia Sales Analysis and Forecast, by Key Segments and Countries
• 16. South Asia Sales Analysis and Forecast, by Key Segments and Countries
• 17. Oceania Sales Analysis and Forecast, by Key Segments and Countries
• 18. Middle East and Africa (MEA) Sales Analysis and Forecast, by Key Segments and Countries
• 19. Sales Forecast by Product, Test Type, Technology, and End User for 30 Countries
• 20. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard
• 21. Company Profile
  • 21.1. Bio-Rad Laboratories
  • 21.2. Covidien PLC
  • 21.3. GE Life Sciences
  • 21.4. Masimo Corporation
  • 21.5. Natus Medical Inc.
  • 21.6. PerkinElmer Inc.
  • 21.7. Trivitron Healthcare
  • 21.8. GE Healthcare
  • 21.9. ZenTech S.A
  • 21.10. Novartis AG